To enhance the diagnostic value of Cripto-1/AFP expression for early recurrence of HCC, we further performed a receiver-operating characteristic (ROC) curve analysis to determine the efficacy of Cripto-1 and serum AFP expression in discriminating early recurrence in HCC patients. The gene discussed is AFP; the disease is hepatocellular carcinoma.